Literatura académica sobre el tema "Drug-reduced regimens"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Drug-reduced regimens".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Drug-reduced regimens"
VanScoy, Brian, Jennifer McCauley, Sujata M. Bhavnani, Evelyn J. Ellis-Grosse y Paul G. Ambrose. "Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model". Antimicrobial Agents and Chemotherapy 60, n.º 9 (6 de junio de 2016): 5141–45. http://dx.doi.org/10.1128/aac.00355-16.
Texto completoAng, Zen Yang, Kit Yee Cheah, Nadiah B. Abdullah, Safawati B. Samsuri, Siao Hui Lee, Andrew WH Yem y Malathi AP Sriraman. "Parenteral cytotoxic drug wastage at a tertiary hospital in Kuala Lumpur: How much and why?" Journal of Oncology Pharmacy Practice 26, n.º 6 (6 de diciembre de 2019): 1306–17. http://dx.doi.org/10.1177/1078155219891209.
Texto completoVia, Laura E., Kathleen England, Danielle M. Weiner, Daniel Schimel, Matthew D. Zimmerman, Emmanuel Dayao, Ray Y. Chen et al. "A Sterilizing Tuberculosis Treatment Regimen Is Associated with Faster Clearance of Bacteria in Cavitary Lesions in Marmosets". Antimicrobial Agents and Chemotherapy 59, n.º 7 (4 de mayo de 2015): 4181–89. http://dx.doi.org/10.1128/aac.00115-15.
Texto completoRhee, Soo-Yon, Philip M. Grant, Philip L. Tzou, Geoffrey Barrow, P. Richard Harrigan, John P. A. Ioannidis y Robert W. Shafer. "A systematic review of the genetic mechanisms of dolutegravir resistance". Journal of Antimicrobial Chemotherapy 74, n.º 11 (5 de julio de 2019): 3135–49. http://dx.doi.org/10.1093/jac/dkz256.
Texto completoTasneen, Rokeya, Fabrice Betoudji, Sandeep Tyagi, Si-Yang Li, Kathy Williams, Paul J. Converse, Véronique Dartois et al. "Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis". Antimicrobial Agents and Chemotherapy 60, n.º 1 (26 de octubre de 2015): 270–77. http://dx.doi.org/10.1128/aac.01691-15.
Texto completoHawkins, Trevor, Wenoah Veikley, Lucie Durand-Gasselin, Darius Babusis, Y. Sunila Reddy, John F. Flaherty y Adrian S. Ray. "Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected Patients". Antimicrobial Agents and Chemotherapy 55, n.º 4 (31 de enero de 2011): 1549–55. http://dx.doi.org/10.1128/aac.00910-10.
Texto completoZhdanov, Konstantin V., Oleg V. Maltsev, Kristina V. Kasyanenko, Konstantin V. Kozlov, Vitalii S. Sukachev, Nikolai I. Lvov, Valerian V. Sharabkhanov y Alexander A. Litvinov. "Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults". Terapevticheskii arkhiv 95, n.º 11 (22 de diciembre de 2023): 930–36. http://dx.doi.org/10.26442/00403660.2023.11.202471.
Texto completoDutta, Noton K., Michael L. Pinn y Petros C. Karakousis. "Reduced Emergence of Isoniazid Resistance with Concurrent Use of Thioridazine against Acute Murine Tuberculosis". Antimicrobial Agents and Chemotherapy 58, n.º 7 (5 de mayo de 2014): 4048–53. http://dx.doi.org/10.1128/aac.02981-14.
Texto completoJung, H., R. Medina, N. Castro, T. Corona y J. Sotelo. "Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen." Antimicrobial Agents and Chemotherapy 41, n.º 6 (junio de 1997): 1256–59. http://dx.doi.org/10.1128/aac.41.6.1256.
Texto completoTyczyńska, Agata, Marcela Krzysława Krzempek, Alexander Jorge Cortez, Artur Jurczyszyn, Katarzyna Godlewska, Hanna Ciepłuch, Edyta Subocz et al. "The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age". Cancers 15, n.º 13 (2 de julio de 2023): 3469. http://dx.doi.org/10.3390/cancers15133469.
Texto completoTesis sobre el tema "Drug-reduced regimens"
Palich, Romain. "Impact de la résistance virale acquise dans le passé sur les stratégies antirétrovirales actuelles". Electronic Thesis or Diss., Sorbonne université, 2021. http://www.theses.fr/2021SORUS493.
Texto completoIn the field of HIV management, today in France, three situations continue to concern clinicians: 1) persistent low-level viremia, despite prolonged antiretroviral treatment and good self-reported compliance, 2) persistence or clearance in viral reservoir of resistance mutations selected in the past, and 3) optimal drug-reduced antiretroviral treatment in virally suppressed patients. In a first work, we showed that 72% of patients with persistent low-level viremia, with good self-reported compliance, had adequate plasma antiretroviral concentrations, and no past viral resistance explaining the persistent replication. Two years after inclusion, 72% of patients maintained low-level replication without virologic failure. In a second work, we showed the persistence of the M184V mutation, acquired in the past, in 67% of patients with suppressed viremia >5 years (detection threshold: 1%), as well as the progressive clearance of the mutation in the HIV-DNA reservoir. The two factors associated with the persistence of M184V were the duration and the level of replication under 3TC/FTC in the past. In a third work, we showed the virological efficacy of dual therapies given 5 or 4 days a week (virological success: 91% at W96), in a population highly exposed to antiretroviral treatment. Overall, these findings support the optimization of strategies, in order to reduce the exposure to antiretrovirals, including in patients with a long virological and therapeutic history
Libros sobre el tema "Drug-reduced regimens"
Harper, Lorraine y David Jayne. The patient with vasculitis. Editado por Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0160.
Texto completoJayne, David. Treatment of ANCA-associated vasculitis. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0132.
Texto completoCapítulos de libros sobre el tema "Drug-reduced regimens"
Onida, Francesco y Yves Chalandon. "Myelodysplastic/Myeloproliferative Neoplasms". En The EBMT Handbook, 685–94. Cham: Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_76.
Texto completoSzturz, Petr y Jan B. Vermorken. "Systemic Treatment Sequencing and Prediction of First-line Therapy Outcomes in Recurrent or Metastatic Head and Neck Cancer". En Critical Issues in Head and Neck Oncology, 199–215. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23175-9_13.
Texto completoBrater, D. Craig. "Antimicrobial dosing regimens in renal patients". En Infectious complications renal disease, 431–48. Oxford University PressNew York, NY, 2003. http://dx.doi.org/10.1093/oso/9780192632944.003.0021.
Texto completoFabris, Marcieli, Kaio Maciel de Santiago-Silva, Camilo Henrique da Silva Lima, Marcelle de Lima Ferreira Bispo y Priscila Goes Camargo. "Anti-trypanosomatid Drugs/Candidates in Clinical Trials: What's New and What's Missing?" En Frontiers in Drug Design and Discovery: Volume 12, 1–63. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815165258123120002.
Texto completoJayne, David. "Treatment of ANCA-associated vasculitis". En Oxford Textbook of Rheumatology, 1103–12. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0132_update_001.
Texto completoGoldsmith, William W. "Drug-War Politics". En Saving Our Cities. Cornell University Press, 2016. http://dx.doi.org/10.7591/cornell/9781501704314.003.0008.
Texto completoRaj Daniel Raj Ponniah, Lional. "Alternative Treatment Approaches in Bacterial Keratitis". En Keratitis - Current Perspectives [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.112624.
Texto completoCarpenter, John P., John C. Wood y Dudley J. Pennell. "Myocardial iron overload". En The EACVI Textbook of Cardiovascular Magnetic Resonance, editado por Massimo Lombardi, Sven Plein, Steffen Petersen, Chiara Bucciarelli-Ducci, Emanuela R. Valsangiacomo Buechel, Cristina Basso y Victor Ferrari, 364–74. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198779735.003.0033.
Texto completoK, Dr Vini, Veena V.P y Dr Nissamudeen K. M. "FUTURISTIC TRENDS IN NANOTECHNOLOGY". En Futuristic Trends in Chemical, Material Sciences & Nano Technology Volume 2 Book 13, 177–89. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2023. http://dx.doi.org/10.58532/v2bs13p3ch3.
Texto completoPost, Robert M. "Lithium and related mood stabilizers". En New Oxford Textbook of Psychiatry, 1198–208. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199696758.003.0154.
Texto completoActas de conferencias sobre el tema "Drug-reduced regimens"
Versteeg, Henk K., Graham K. Hargrave, Perry A. Genova, Robert C. Williams, Dan Deaton y Prashant Kakade. "Design Optimisation of Novel Pharmaceutical Actuator Using Optical Diagnostics". En ASME 7th Biennial Conference on Engineering Systems Design and Analysis. ASMEDC, 2004. http://dx.doi.org/10.1115/esda2004-58173.
Texto completoNeri Semeri, G. G., F. Rovelli, G. F. Gensini, S. Pirelli, M. Carnovali y A. Fortini. "FREVENTION OF MYOCARDIAL REINFARCTION BY LOW DOSE HEPARIN". En XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643597.
Texto completoShelyakin, I. D., S. N. Semenov y L. V. Cheskidova. "THE STUDY OF EFFECTS OF АMINOTONE ON HEMATOLOGICAL AND BIOCHEMICAL STATUS OF DOGS IN BABESIOSIS THERAPY". En THEORY AND PRACTICE OF PARASITIC DISEASE CONTROL. All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV”, 2023. http://dx.doi.org/10.31016/978-5-6048555-6-0.2023.24.532-537.
Texto completoIsabekov, N. R. "METHOD OF RESPIRATORY SUPPORT FOR ACUTE CHEMICAL LUNG LESIONS OF PROFESSIONAL GENESIS". En The 4th «OCCUPATION and HEALTH» International Youth Forum (OHIYF-2022). FSBSI «IRIOH», 2022. http://dx.doi.org/10.31089/978-5-6042929-6-9-2022-1-87-90.
Texto completoInformes sobre el tema "Drug-reduced regimens"
Jorgensen, Frieda, Andre Charlett, Craig Swift, Anais Painset y Nicolae Corcionivoschi. A survey of the levels of Campylobacter spp. contamination and prevalence of selected antimicrobial resistance determinants in fresh whole UK-produced chilled chickens at retail sale (non-major retailers). Food Standards Agency, junio de 2021. http://dx.doi.org/10.46756/sci.fsa.xls618.
Texto completo